SANUWAVE Health, Inc. Common Stock (SNWV)

• Market cap: $308M
• 1 day: 3.54%
• 5 days: -4.59%
• 1 month: 9.53%
• 3 months: 33.05%
• 6 months: 24.10%
• Year to date: 24.10%
• 1 year: 24.10%
• 5 years: 24.10%
• 10 years: 24.10%
• Sector: Healthcare
• Industry: Medical Devices

About: SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

Employees: 46

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

288,512% more capital invested

Capital invested by funds: $30.7K [Q4 2024] → $88.5M (+$88.5M) [Q1 2025]

1,800% more funds holding

Funds holding: 1 [Q4 2024] → 19 (+18) [Q1 2025]

29.26% more ownership

Funds ownership: 0% [Q4 2024] → 29.26% (+29.26%) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $49 36% upside
• Avg. target: $49 36% upside
• High target: $49 36% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Roth Capital Kyle Bauser

36% upside $49

Buy Initiated

29 Jul 2025